Literature DB >> 23147471

Negative symptoms and executive function in schizophrenia: does their relationship change with illness duration?

Alexandra Bagney1, Roberto Rodriguez-Jimenez, Isabel Martinez-Gras, Eva Maria Sanchez-Morla, Jose Luis Santos, Miguel Angel Jimenez-Arriero, Antonio Lobo, Patrick D McGorry, Tomas Palomo.   

Abstract

BACKGROUND: Negative symptoms and cognitive dysfunction are of crucial functional and prognostic importance in schizophrenia. However, the nature of the relationship between them and the factors that may influence it have not been well established. AIMS: To investigate whether the relationship between negative symptoms and executive function changes according to the duration of illness in schizophrenia.
METHODS: The Positive and Negative Syndrome Scale was used to assess psychopathology and the Wisconsin Card Sorting Test (WCST) to evaluate executive function in a sample of 200 schizophrenic patients who were classified in 3 groups according to their duration of illness: up to 5 years (short duration group), 6-20 years (intermediate duration group) and over 20 years of illness (long duration group).
RESULTS: Medium-sized correlations were found between negative symptoms and WCST performance as assessed by the number of completed categories in all 3 groups. However, differences were found according to the duration of schizophrenia. For patients in the short duration group, negative symptoms correlated with WCST nonperseverative errors, but for those in the long duration group the correlation was with perseverative errors.
CONCLUSION: We found a differential relationship between negative and cognitive symptoms in different stages of schizophrenia. Illness duration should be considered when studying the relationship between negative symptoms and cognition.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 23147471     DOI: 10.1159/000342345

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  15 in total

1.  Measuring pathology using the PANSS across diagnoses: Inconsistency of the positive symptom domain across schizophrenia, schizoaffective, and bipolar disorder.

Authors:  Ariana E Anderson; Maxwell Mansolf; Steven P Reise; Adam Savitz; Giacomo Salvadore; Qingqin Li; Robert M Bilder
Journal:  Psychiatry Res       Date:  2017-08-16       Impact factor: 3.222

2.  Variants Near CCK Receptors are Associated With Electrophysiological Responses to Pre-pulse Startle Stimuli in a Mexican American Cohort.

Authors:  Trina M Norden-Krichmar; Ian R Gizer; Evelyn Phillips; Kirk C Wilhelmsen; Nicholas J Schork; Cindy L Ehlers
Journal:  Twin Res Hum Genet       Date:  2015-11-26       Impact factor: 1.587

3.  Neuropsychological and cerebral morphometric aspects of negative symptoms in schizophrenia: negative symptomatology is associated with specific mnestic deficits in schizophrenic patients.

Authors:  Tobias Hornig; Gabi Valerius; Bernd Feige; Emanuel Bubl; Hans M Olbrich; Ludger Tebartz van Elst
Journal:  BMC Psychiatry       Date:  2014-11-25       Impact factor: 3.630

4.  Cognitive impairment in schizophrenia across age groups: a case-control study.

Authors:  Anna Mosiołek; Jacek Gierus; Tytus Koweszko; Agata Szulc
Journal:  BMC Psychiatry       Date:  2016-02-24       Impact factor: 3.630

5.  The relationship between moderate-to-vigorous physical activity and executive function among individuals with schizophrenia: differences by illness duration.

Authors:  Viviane Grassmann; Mehala Subramaniapillai; Mark Duncan; Kelly Arbour-Nicitopoulos; Guy E Faulkner
Journal:  Braz J Psychiatry       Date:  2017-03-30       Impact factor: 2.697

6.  Role of Executive Function in Response to a Problem Solving Based Psychoeducational Intervention in Adolescents with Psychosis: The PIENSA Trial Revisited.

Authors:  Marta Rapado-Castro; Carmen Moreno; Ana Ruíz-Sancho; Francisco Camino; Celso Arango; Maria Mayoral
Journal:  J Clin Med       Date:  2019-12-02       Impact factor: 4.241

7.  The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Naïve Patients With Schizophrenia.

Authors:  Xing-Jie Peng; Gang-Rui Hei; Ye Yang; Chen-Chen Liu; Jing-Mei Xiao; Yu-Jun Long; Jing Huang; Jing-Ping Zhao; Ren-Rong Wu
Journal:  Front Psychiatry       Date:  2021-02-25       Impact factor: 4.157

8.  Impairment of Executive Functions Associated With Lower D-Serine Serum Levels in Patients With Schizophrenia.

Authors:  Jaromir Hons; Rastislav Zirko; Martina Vasatova; Pavel Doubek; Blanka Klimova; Jiri Masopust; Martin Valis; Kamil Kuca
Journal:  Front Psychiatry       Date:  2021-03-29       Impact factor: 4.157

9.  Nature and Correlates of Executive Dysfunction in Schizophrenia: An Exploratory Study.

Authors:  Joseph Noel; Shonima A Viswanathan; Anju Kuruvilla
Journal:  Indian J Psychol Med       Date:  2020-08-10

10.  Negative symptoms in schizophrenia: a study in a large clinical sample of patients using a novel automated method.

Authors:  Rashmi Patel; Nishamali Jayatilleke; Matthew Broadbent; Chin-Kuo Chang; Nadia Foskett; Genevieve Gorrell; Richard D Hayes; Richard Jackson; Caroline Johnston; Hitesh Shetty; Angus Roberts; Philip McGuire; Robert Stewart
Journal:  BMJ Open       Date:  2015-09-07       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.